Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

356 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Causes of HIV Treatment Interruption during the Last 20 Years: A Multi-Cohort Real-Life Study.
De Vito A, Ricci E, Menzaghi B, Orofino G, Martinelli CV, Squillace N, Taramasso L, De Socio GV, Molteni C, Valsecchi L, Costa C, Celesia BM, Parruti G, Pellicanò GF, Sarchi E, Cascio A, Cenderello G, Falasca K, Di Biagio A, Bonfanti P, Madeddu G. De Vito A, et al. Among authors: bonfanti p. Viruses. 2023 Mar 10;15(3):720. doi: 10.3390/v15030720. Viruses. 2023. PMID: 36992429 Free PMC article.
Risk factors for lipodystrophy in the CISAI cohort.
Bonfanti P, Gulisano C, Ricci E, Timillero L, Valsecchi L, Carradori S, Pusterla L, Fortuna P, Miccolis S, Magnani C, Gabbuti A, Parazzini F, Martinelli C, Faggion I, Landonio S, Quirino T, Vigevani G; Coordinamento Italiano Studio Allergia e Infezione da HIV (CISAI) Group. Bonfanti P, et al. Biomed Pharmacother. 2003 Nov;57(9):422-7. doi: 10.1016/j.biopha.2003.06.002. Biomed Pharmacother. 2003. PMID: 14652168 Clinical Trial.
An Italian approach to postmarketing monitoring: preliminary results from the SCOLTA (Surveillance Cohort Long-Term Toxicity Antiretrovirals) project on the safety of lopinavir/ritonavir.
Bonfanti P, Martinelli C, Ricci E, Carradori S, Parruti G, Armignacco O, Magnani C, Quirino T; CISAI Group (Italian Coordinators for the Study of Allergies HIV Infection). Bonfanti P, et al. J Acquir Immune Defic Syndr. 2005 Jul 1;39(3):317-20. doi: 10.1097/01.qai.0000164248.56722.3c. J Acquir Immune Defic Syndr. 2005. PMID: 15980692
Metabolic syndrome: a real threat for HIV-positive patients?: Results from the SIMONE study.
Bonfanti P, Ricci E, de Socio G, Zeme D, Carradori S, Penco G, Parruti G, Grosso C, Madeddu G, Vichi F, Bini T, Martinelli C, Melzi S, Quirino T; CISAI Study Group. Bonfanti P, et al. J Acquir Immune Defic Syndr. 2006 May;42(1):128-31. doi: 10.1097/01.qai.0000219775.20174.2d. J Acquir Immune Defic Syndr. 2006. PMID: 16763502 No abstract available.
[Renal toxicity in HIV-infected patients receiving HAART including tenofovir].
Madeddu G, Quirino T, Carradori S, Ricci E, Grosso C, Penco G, De Socio G, Rossella E, Palvarini L, Marconi P, Melzi S, Mura MS, Bonfanti P; Gruppo CISAI. Madeddu G, et al. Among authors: bonfanti p. Infez Med. 2006 Sep;14(3):125-34. Infez Med. 2006. PMID: 17127826 Free article. Review. Italian.
Tenofovir renal safety in HIV-infected patients: results from the SCOLTA Project.
Madeddu G, Bonfanti P, De Socio GV, Carradori S, Grosso C, Marconi P, Penco G, Rosella E, Miccolis S, Melzi S, Mura MS, Landonio S, Ricci E, Quirino T; CISAI Group. Madeddu G, et al. Among authors: bonfanti p. Biomed Pharmacother. 2008 Jan;62(1):6-11. doi: 10.1016/j.biopha.2007.04.008. Epub 2007 May 29. Biomed Pharmacother. 2008. PMID: 17574807
Identifying HIV patients with an unfavorable cardiovascular risk profile in the clinical practice: results from the SIMONE study.
De Socio GV, Parruti G, Quirino T, Ricci E, Schillaci G, Adriani B, Marconi P, Franzetti M, Martinelli C, Vichi F, Penco G, Sfara C, Madeddu G, Bonfanti P; CISAI study group. De Socio GV, et al. Among authors: bonfanti p. J Infect. 2008 Jul;57(1):33-40. doi: 10.1016/j.jinf.2008.03.007. Epub 2008 Apr 24. J Infect. 2008. PMID: 18436307
356 results